Research ArticleCardiovascular
ETA RECEPTORS BLOCKADE, BY ACTIVATING ETB RECEPTORS, INCREASES VASCULAR PERMEABILITY AND INDUCES EXAGGERATED FLUID RETENTION.
Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
Journal of Pharmacology and Experimental Therapeutics February 21, 2017, jpet.116.234930; DOI: https://doi.org/10.1124/jpet.116.234930
Magali Vercauteren
1 Actelion Pharmaceuticals limited;
Frederic Trensz
1 Actelion Pharmaceuticals limited;
Anne Pasquali
1 Actelion Pharmaceuticals limited;
Christophe Cattaneo
1 Actelion Pharmaceuticals limited;
Daniel S Strasser
1 Actelion Pharmaceuticals limited;
Patrick Hess
1 Actelion Pharmaceuticals limited;
Marc Iglarz
2 Actelion Pharmaceuticals Ltd.
Martine Clozel
1 Actelion Pharmaceuticals limited;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
ETA RECEPTORS BLOCKADE, BY ACTIVATING ETB RECEPTORS, INCREASES VASCULAR PERMEABILITY AND INDUCES EXAGGERATED FLUID RETENTION.
Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
Journal of Pharmacology and Experimental Therapeutics February 21, 2017, jpet.116.234930; DOI: https://doi.org/10.1124/jpet.116.234930
Research ArticleCardiovascular
ETA RECEPTORS BLOCKADE, BY ACTIVATING ETB RECEPTORS, INCREASES VASCULAR PERMEABILITY AND INDUCES EXAGGERATED FLUID RETENTION.
Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
Journal of Pharmacology and Experimental Therapeutics February 21, 2017, jpet.116.234930; DOI: https://doi.org/10.1124/jpet.116.234930
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement